Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment

Research output: Contribution to journal › Article › Academic › peer-review

87 Citations (Scopus)

Original language	English
Pages (from-to)	284-285
Number of pages	2
Journal	Annals of the Rheumatic Diseases
Volume	68
Issue number	2
DOIs	https://doi.org/10.1136/ard.2008.092601
Publication status	Published - 12 Jan 2009
Externally published	Yes

Access to Document

@article{f9c0a309ca08418c9f5dc5e97cc390b9,

title = "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment",

author = "Meijer, \{J M\} and J Pijpe and A Vissink and Kallenberg, \{C G M\} and H Bootsma",

year = "2009",

month = jan,

day = "12",

doi = "10.1136/ard.2008.092601",

language = "English",

volume = "68",

pages = "284--285",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Treatment of primary Sjogren syndrome with rituximab

T2 - extended follow-up, safety and efficacy of retreatment

AU - Meijer, J M

AU - Pijpe, J

AU - Vissink, A

AU - Kallenberg, C G M

AU - Bootsma, H

PY - 2009/1/12

Y1 - 2009/1/12

U2 - 10.1136/ard.2008.092601

DO - 10.1136/ard.2008.092601

M3 - Article

C2 - 19139205

SN - 0003-4967

VL - 68

SP - 284

EP - 285

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 2

ER -